Search

International variations in ROP treatment

A retrospective cohort review of 48,087 premature infants weighing <1500 gm between 24 to 27 weeks gestation, from 11 high income countries in Australia, New Zealand, Canada, Finland, Israel, Japan, Spain, Sweden, Switzerland, Tuscany (Italy) and the UK . By...

ROP and weight gain

The authors aimed to examine the relationship between postnatal weight gain and development of retinopathy of prematurity (ROP) among very preterm infants. They examined weight changes in the early postnatal period from birth to the first day of established full...

ROP risk factors

The purpose of this study was to evaluate the incidence and risk factors for retinopathy of prematurity (ROP) in two neo-natal units, and included a sub-analysis of infants with gestational age (GA) of ≥28 weeks. A retrospective review was undertaken...

ROP screening criteria

This study aimed to describe a process of identifying birth weight and gestational age screening guidelines in Mongolia using telemedicine for retinopathy of prematurity (ROP) screening. This was a single centre prospective study collecting data from December 2016 to January...

ROPScore for detection of any and severe ROP

ROPScore is a free tool consisting of a logistic regression equation to calculate the risk per child and calculated one time per infant at six weeks of life. It helps to predict severe retinopathy of prematurity (ROP). This study aimed...

Incidence, characteristics and risk factors for ROP

This is a retrospective study performed at Seoul St Mary’s Hospital between the period of January 2009 to December 2013. The study was to determine the incidence and clinical features of, and risk factors for, retinopathy of prematurity (ROP) in...

Telemedicine retinopathy of prematurity (ROP) screening

The Auckland Regional Telemedicine ROP network utilises wide-field digital imaging for ROP screening. Results are from 2006-2015; 1181 infants were screened over three neonatal intensive care units; 83 infants with ROP were identified. Screening rates increased over the 10 years...

Refraction results in ROP with and without IVB

The authors aimed to compare refractive results of intravitreal bevacizumab (IVB) injection in premature neonates with retinopathy of prematurity (ROP) versus infants with spontaneous regression of ROP. The study included 87 infants (174 eyes). Group 1 included 38 infants (76...

Review of international telemedicine infrastructure for ROP

This review aimed to review the information and communications technology available for telemedicine, the internet access and economic status of countries at greater risk for higher prevalence of ROP, the framework of established ROP telemedicine programmes, and the cost-effectiveness of...

ROP anti-VEGF treatment review

The purpose of this review was to consider data relating to risks and benefits of the use of anti-VEGF treatment for retinopathy of prematurity (ROP) over the past five years of 2015-2020. Ocular benefits include treatment of aggressive posterior ROP,...

Efficacy of IVC injection in the treatment of ROP

This is a retrospective consecutive case series of patients who received intravitreal conbercept (IVC) as a primary treatment from June 2015 to July 2016 for treatment of retinopathy of prematurity (ROP). Forty-eight eyes of 24 patients were included in the...

Treatment efficacy of stage 4 ROP

This study aimed to determine the efficacy of combined vitrectomy and anti-VEGF injection for advanced stage 4 ROP with extensive neovascular proliferation (NF). The study included nine infants; six bilateral and three unilateral. Seven were female and the mean gestational...